Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann Sep 24, 2021 09:00AM
Hancock Jaffe Laboratories (HJLI) Announces $20M Direct At-the-Market Offering at $7.87 Sep 7, 2021 08:07AM
Hancock Jaffe Laboratories Announces $20 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules Sep 7, 2021 08:05AM
Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference Jul 8, 2021 09:05AM
Hancock Jaffe Completes $41 Million Public Offering Feb 11, 2021 04:05PM


Feb 9, 2021 08:47AM Hancock Jaffe Laboratories (HJLI) Prices 5.143M Unit
Feb 9, 2021 08:30AM Hancock Jaffe Laboratories Announces Pricing of Upsized $36 Million Offering
Dec 16, 2020 08:30AM Hancock Jaffe Reports Two CoreoGraft Patients Have Reached 30 Day Milestone
Dec 15, 2020 04:18PM Hancock Jaffe Laboratories (HJLI) Announces Significant Improvements in all Study Endpoints For Final VenoValve First-in-Human Data
Dec 15, 2020 04:15PM Hancock Jaffe Announces Significant Improvements in all Study Endpoints For Final VenoValve First-in-Human Data
Dec 10, 2020 08:30AM Hancock Jaffe to Provide VenoValve and CoreoGraft Updates at Ladenburg Thalmann R&D Showcase Webinar on December 16, 2020
Oct 7, 2020 08:33AM Hancock Jaffe Laboratories (HJLI) Prices $5.1M Registered Direct Offering
Oct 7, 2020 08:30AM Hancock Jaffe Laboratories, Inc. Announces Pricing of $5.1 Million Registered Direct Offering Priced at the Market
Jul 21, 2020 04:01PM Hancock Jaffe Laboratories Announces Closings of $6.2 Million Offerings Including Full Exercise of Over-Allotment Option
Jul 17, 2020 10:00AM Hancock Jaffe Laboratories (HJLI) Prices 12.5M Unit Offering at $0.32/Unit
Jul 17, 2020 09:40AM Hancock Jaffe Laboratories Announces Pricing of $5.6 Million Offering